Outcomes of nonsuspicious contralateral nodules with active surveillance after lobectomy in patients with papillary thyroid carcinoma
- PMID: 35909520
- PMCID: PMC9337856
- DOI: 10.3389/fendo.2022.941080
Outcomes of nonsuspicious contralateral nodules with active surveillance after lobectomy in patients with papillary thyroid carcinoma
Abstract
Objective: To observe the outcomes of nonsuspicious contralateral nodules with active surveillance in patients with papillary thyroid carcinoma (PTC).
Methods: 4pt?>Consecutive patients who underwent lobectomy for PTC were retrospectively reviewed. Patients with one or more nodules with nonsuspicious ultrasonography (US) features in the contralateral lobe were included.
Results: Two hundred and eighty-three patients were included. All patients underwent thyroid lobectomy with ipsilateral prophylactic central neck dissection. A total of 123 patients (43.5%) were classified as ATA low-risk, and 160 patients (56.5%) were classified as intermediate-risk. The median size of the contralateral nodules was 3 mm (range, 2 to 16 mm). After a period of follow-up, the median size change of contralateral nodules was 0 mm (range, -7 to 8 mm). Eight patients (2.8%) had nodule growth >3 mm, 223 patients (78.8%) had stable or decreased nodules, and 52 patients (18.4%) had no detectable nodules. Nodules in 24 patients had suspicious US features, 16 of which were diagnosed with PTMC by either cytology after FNA (in 7 patients) or histopathology after completion thyroidectomy (in 9 patients). Another four patients received completion thyroidectomy for ipsilateral cervical lymph node metastasis. The 5-year residual lobe recurrence (RLR) rate and recurrence-free survival (RFS) rate were 7.4% and 89.8%, respectively. Multivariate analysis showed that multifocality and ATA intermediate-risk were independent predictors for RLR (HR4.083, 95%CI 1.480-11.261, P = 0.007; HR 6.045, 95%CI 1.370-26.662, P = 0.017, respectively) and RFS (HR 5.240, 95%CI 2.114-12.991, P < 0.001; HR 5.223, 95%CI 1.353-17.765, P = 0.008, respectively).
Conclusions: Active surveillance for nonsuspicious contralateral nodules in patients with low-risk and selected intermediate-risk PTC is safe. Multifocality and ATA intermediate-risk are predicters for recurrence. Early detection and salvage surgery are effective.
Keywords: active surveillance; papillary carcinoma; thyroid cancer; thyroid nodules; thyroidectomy.
Copyright © 2022 Huang, Liu, Wang and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Natural History of Contralateral Nodules After Lobectomy in Patients With Papillary Thyroid Carcinoma.J Clin Endocrinol Metab. 2018 Feb 1;103(2):407-414. doi: 10.1210/jc.2017-01616. J Clin Endocrinol Metab. 2018. PMID: 29240898
-
Should Contralateral Nodules Be an Indication of Total or Completion Thyroidectomy for Patients With Unilateral Papillary Thyroid Carcinoma?Front Endocrinol (Lausanne). 2021 Aug 9;12:723631. doi: 10.3389/fendo.2021.723631. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34434171 Free PMC article.
-
Extent of surgery for unilateral papillary thyroid cancer with nonsuspicious contralateral nodules by ultrasound.Endocrine. 2024 Oct;86(1):276-283. doi: 10.1007/s12020-024-03850-z. Epub 2024 May 4. Endocrine. 2024. PMID: 38703328
-
Recommend with caution: A meta-analysis investigating papillary thyroid carcinoma tumor progression under active surveillance.Am J Otolaryngol. 2023 Nov-Dec;44(6):103994. doi: 10.1016/j.amjoto.2023.103994. Epub 2023 Jul 17. Am J Otolaryngol. 2023. PMID: 37607459 Review.
-
Approach to the Patient With Thyroid Cancer: Selection and Management of Candidates for Lobectomy.J Clin Endocrinol Metab. 2025 Jun 17;110(7):e2327-e2337. doi: 10.1210/clinem/dgae903. J Clin Endocrinol Metab. 2025. PMID: 39745824 Review.
Cited by
-
Predicting Extrathyroidal Extension in Papillary Thyroid Carcinoma Using a Clinical-Radiomics Nomogram Based on B-Mode and Contrast-Enhanced Ultrasound.Diagnostics (Basel). 2023 May 13;13(10):1734. doi: 10.3390/diagnostics13101734. Diagnostics (Basel). 2023. PMID: 37238217 Free PMC article.
References
-
- Brito JP, Al Nofal A, Montori VM, Hay ID, Morris JC. The impact of subclinical disease and mechanism of detection on the rise in thyroid cancer incidence: A population-based study in Olmsted county, Minnesota during 1935 through 2012. Thyroid (2015) 25(9):999–1007. doi: 10.1089/thy.2014.0594 - DOI - PMC - PubMed
-
- Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. . 2015 American Thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid (2016) 26(1):1–133. doi: 10.1089/thy.2015.0020 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials